Latest filing published 26 Aug 2026 for 10x Genomics, Inc., €746k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Benjamin J. Hindson appears in our data through filings on 10x Genomics, Inc. shares, published by SEC (Form 4). The record holds 42 filings, for trades running from 19 March 2021 to 24 August 2026.
On the market, this insider has only sold: 21 sales, €2.4M in total. Other entries cover 7 share grants and 14 option exercises. 2026 to date brings no purchases and 3 sales.
Most recently, on 26 August 2026, the filings show an open-market sale worth €746k in 10x Genomics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 42 declarations